Fagron shareholders approve majority voting items

Fagron shareholders approve majority voting items

Today, Fagron, the leading global player in pharmaceutical compounding, held its annual general meeting of shareholders. The meeting approved the voting items, with the exemption of the proposal to approve the accelerated vesting in case of a public offer on or a change of control over Fagron as provided for in the Performance Share Plan (agenda item 10). This provision will be deleted from the plan.

Full press release